Alcachupas Aljeirou, Bellosillo Krisverlyn, Catolico Wynlee Rhm, Davis Mark Cullen, Diaz Alyssa, Doyongan Yvette Karla, Eduarte Reczy, Gersava Emerald, Intrepido Mary Bernadette, Laluma Maugri Grace Kristi, Lavalle Candra Carmelli, Millan Jeffrey
College of Medicine, West Visayas State University, Iloilo City, PHL.
Cureus. 2023 Jun 23;15(6):e40856. doi: 10.7759/cureus.40856. eCollection 2023 Jun.
Thrombosis is one of the leading causes of mortality worldwide. Thrombolytic agents are used to reduce this burden. Studies pointed out that certain proteins in the venom of several snake species may have potential thrombolytic properties. , known as the Philippine pit viper, is found along damp localities in the Philippines. Venoms of closely related species have been shown to exhibit thrombolytic effects in vitro and in vivo. However, no extensive studies yet have been conducted about the thrombolytic effect of venom. Thus, this two-phased study aimed to determine the thrombolytic effect of venom on human blood and ferric chloride-induced cardiac thrombosis in mice.
Phase 1 was done using clot lysis method to measure thrombolytic activity in vitro. Venom dilutions of 3:4, 1:2, 2:3, and 1:0, positive control (streptokinase), and negative control (normal saline solution) were inoculated to different samples of human blood. Phase 2 measured the thrombolytic activity in vivo. Ferric chloride-saturated filter paper was applied over the cardiac wall for the induction of thrombus formation. Venom dilutions of 1:64, 1:16, 1:4, and 1:1, positive control (streptokinase), and negative control (normal saline solution) were then injected through the dorsal tail vein of mice. After 1 hour, the cardiac tissues were excised for histologic examination.
Phase 1 results showed that the venom had significant thrombolytic activity in vitro. Dilutions of 1:0 and 3:4 had no significant differences with streptokinase in vitro. Phase 2 results showed significant lysis in vivo at 1:1, 1:4, and 1:64 venom dilutions.
The results indicated that has a potential thrombolytic activity both in vitro and in vivo.
血栓形成是全球主要的致死原因之一。溶栓药物被用于减轻这一负担。研究指出,几种蛇类毒液中的某些蛋白质可能具有潜在的溶栓特性。(此处原文缺失蛇的具体种类名称),即菲律宾蝰蛇,在菲律宾的潮湿地区被发现。与之亲缘关系较近的蛇类的毒液已被证明在体外和体内均表现出溶栓作用。然而,关于(此处原文缺失蛇的具体种类名称)毒液的溶栓作用尚未进行广泛研究。因此,这项分两阶段的研究旨在确定(此处原文缺失蛇的具体种类名称)毒液对人体血液以及对小鼠因氯化铁诱导形成的心脏血栓的溶栓作用。
第一阶段采用凝块溶解法在体外测量溶栓活性。将3:4、1:2、2:3和1:0的毒液稀释液、阳性对照(链激酶)以及阴性对照(生理盐水溶液)接种到不同的人体血液样本中。第二阶段测量体内溶栓活性。将氯化铁饱和的滤纸敷贴在心脏壁上以诱导血栓形成。然后通过小鼠的尾静脉背侧注射1:64、1:16、1:4和1:1的毒液稀释液、阳性对照(链激酶)以及阴性对照(生理盐水溶液)。1小时后,切除心脏组织进行组织学检查。
第一阶段结果表明,该毒液在体外具有显著的溶栓活性。1:0和3:4的稀释液在体外与链激酶无显著差异。第二阶段结果表明,在毒液稀释度为1:1、1:4和1:64时,体内有显著的溶解现象。
结果表明,(此处原文缺失蛇的具体种类名称)在体外和体内均具有潜在的溶栓活性。